GAAP Results
Net sales for the first quarter of 2020 decreased $13.5 million, or 6.3%, to $199.7 million, compared to $213.3 million for the first quarter of 2019, driven by a decrease in organic volume of
On a GAAP basis, loss from operations for the first quarter of 2020 was $245.3 million, compared to a loss from operations of $0.3 million for the same period in 2019. In the first quarter of 2020, the loss from operations included a goodwill impairment charge of
Net loss on a GAAP basis for the first quarter of 2020 was $248.2 million, compared to net loss on a GAAP basis of $19.5 million in the first quarter of 2019.
On a GAAP basis, loss from operations for first quarter 2020 in the Life Sciences segment was $141.0 million, compared to income from operations of
On a GAAP basis, income from operations for first quarter 2020 in the Mobile Solutions segment was $0.3 million, compared to income from operations of $3.2 million for the same period in 2019.
On a GAAP basis, loss from operations for first quarter 2020 in the Power Solutions segment was $90.3 million, compared to income from operations of $3.8 million for the same period in 2019.
Adjusted Results
Adjusted income from operations for the first quarter of 2020 was $17.1 million, compared to $22.4 million for the same period in 2019. Adjusted EBITDA for the first quarter of 2020 was
Life Sciences
Net sales for the first quarter of 2020 were
Mobile Solutions
Net sales for the first quarter of 2020 were
Power Solutions
Net sales for the first quarter of 2020 were
COVID-19 Impact and Response
All of NN's facilities have implemented appropriate safety measures in line with guidance from federal, state and local governmental authorities, including performing employee temperature checks prior to accessing facilities, virus exposure screening, providing personal protective equipment for on-site employees, establishing enhanced disinfecting processes in operational facilities, following social distancing best practices and remote work arrangements.
In light of uncertainty due to COVID-19, NN has taken actions to enhance its financial flexibility and liquidity position, which are expected to generate cash savings of more than
- Temporary wage reductions of 5%-25% for all salaried personnel, and suspension of Board cash compensation;
- Reduction in benefits, including 401(k) matching contribution and gainsharing programs;
- Indirect and SG&A labor reductions;
- CARES Act benefits associated with net operating loss carrybacks that generate cash refunds and FICA remittance deferrals;
- Reductions in travel expenses;
- Rent deferrals;
- Consolidating operating facilities and reducing overall SG&A costs; and
- Reduction in capital expenditures.
In addition to the above actions, NN drew down
Conference Call
NN will discuss its results during its quarterly investor conference call on
NN discloses in this press release the non-GAAP financial measures of adjusted income from operations, adjusted EBITDA, adjusted net income (loss), adjusted net income per diluted share, free cash flow and net debt. Each of adjusted income from operations, adjusted EBITDA, adjusted net income (loss), adjusted net income per diluted share and free cash flow provides supplementary information about the impacts of restructuring and integration expense, acquisition and transition expenses, foreign exchange impacts on inter-company loans, amortization of intangibles and deferred financing costs, and other non-operating impacts on our business. Net debt is defined as debt and finance leases less cash.
The financial tables found later in this press release include a reconciliation of adjusted income from operations, adjusted EBITDA, adjusted net income (loss), adjusted net income (loss) per diluted share and free cash flow to the
About
Except for specific historical information, many of the matters discussed in this press release may express or imply projections of revenues or expenditures, statements of plans and objectives or future operations or statements of future economic performance. These, and similar statements, are forward-looking statements concerning matters that involve risks, uncertainties and other factors which may cause the actual performance of
For additional information concerning such risk factors and cautionary statements, please see the section titled "Risk Factors" in the Company's periodic reports filed with the
Financial Tables Follow
|
||||
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) |
||||
(Unaudited) |
||||
Three Months Ended |
||||
(in thousands, except per share data) |
2020 |
2019 |
||
Net sales |
$ 199,745 |
$ 213,256 |
||
Cost of sales (exclusive of depreciation and amortization shown separately below) |
152,241 |
162,187 |
||
Gross profit (loss) |
47,504 |
51,069 |
||
Selling, general and administrative expense |
24,824 |
28,125 |
||
Depreciation and amortization |
23,184 |
23,425 |
||
Restructuring and integration expense, net |
- |
(12) |
||
|
239,699 |
- |
||
Other operating (income) expense, net |
5,129 |
(152) |
||
Income (loss) from operations |
(245,332) |
(317) |
||
Interest expense |
17,077 |
13,801 |
||
Loss on extinguishment of debt and write-off of debt issuance costs |
- |
2,699 |
||
Other (income) expense, net |
1,120 |
729 |
||
Loss before benefit for income taxes and share of net income from joint venture |
(263,529) |
(17,546) |
||
Benefit (provision) for income taxes |
15,609 |
(2,241) |
||
Share of net income (loss) from joint venture |
(271) |
269 |
||
Net income (loss) |
$ (248,191) |
$ (19,518) |
||
Other comprehensive loss: |
||||
Foreign currency translation gain (loss) |
(14,342) |
1,321 |
||
Interest rate swap: |
||||
Change in fair value of interest rate swap, net of tax |
(11,209) |
(3,856) |
||
Less: reclassification adjustment for (gains) losses included in net income, net of tax |
1,052 |
- |
||
Other comprehensive income (loss) |
(24,499) |
(2,535) |
||
Comprehensive income (loss) |
$ (272,690) |
$ (22,053) |
||
Basic net income (loss) per common share: |
||||
Net income (loss) per common share |
$ (5.96) |
$ (0.47) |
||
Weighted average common shares outstanding |
42,111 |
41,972 |
||
Diluted net income (loss) per common share: |
||||
Net income (loss) per common share |
$ (5.96) |
$ (0.47) |
||
Weighted average common shares outstanding |
42,111 |
41,972 |
|
||||
Condensed Consolidated Balance Sheets |
||||
(Unaudited) |
||||
(in thousands) |
|
|
||
Assets |
||||
Current assets: |
||||
Cash and cash equivalents |
$ 79,214 |
$ 31,703 |
||
Accounts receivable, net |
128,458 |
131,558 |
||
Inventories |
118,919 |
118,722 |
||
Income tax receivable |
17,310 |
5,973 |
||
Other current assets |
19,081 |
15,024 |
||
Total current assets |
362,982 |
302,980 |
||
Property, plant and equipment, net |
350,369 |
374,513 |
||
Operating lease right-of-use assets |
68,407 |
65,496 |
||
|
196,281 |
439,095 |
||
Intangible assets, net |
317,918 |
329,260 |
||
Investment in joint venture |
21,120 |
21,755 |
||
Other non-current assets |
8,076 |
8,885 |
||
Total assets |
$ 1,325,153 |
$ 1,541,984 |
||
Liabilities, Preferred Stock, and Stockholders' Equity |
||||
Current liabilities: |
||||
Accounts payable |
$ 59,792 |
$ 57,340 |
||
Accrued salaries, wages and benefits |
32,138 |
30,428 |
||
Income tax payable |
922 |
1,028 |
||
Current maturities of long-term debt |
20,064 |
19,160 |
||
Current portion of operating lease liabilities |
5,775 |
6,652 |
||
Other current liabilities |
33,842 |
24,873 |
||
Total current liabilities |
152,533 |
139,481 |
||
Deferred tax liabilities |
78,307 |
85,799 |
||
Non-current income tax payable |
- |
1,272 |
||
Long-term debt, net of current portion |
814,972 |
757,440 |
||
Operating lease liabilities, net of current portion |
72,389 |
66,980 |
||
Other non-current liabilities |
32,386 |
44,723 |
||
Total liabilities |
1,150,587 |
1,095,695 |
||
Commitments and contingencies |
||||
Redeemable, convertible preferred stock |
95,664 |
93,012 |
||
Common stock |
428 |
423 |
||
Additional paid-in capital |
499,925 |
501,615 |
||
Warrants |
1,076 |
1,076 |
||
Accumulated deficit |
(353,474) |
(105,283) |
||
Accumulated other comprehensive loss |
(69,053) |
(44,554) |
||
Total stockholders' equity |
78,902 |
353,277 |
||
Total liabilities, preferred stock, and stockholders' equity |
$ 1,325,153 |
$ 1,541,984 |
|
|||
Condensed Consolidated Statements of Cash Flows |
|||
(Unaudited) |
|||
Three Months Ended |
|||
(in thousands) |
2020 |
2019 |
|
Cash flows from operating activities |
|||
Net income (loss) |
$ (248,191) |
$ (19,518) |
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: |
|||
Depreciation and amortization of continuing operations |
23,184 |
23,425 |
|
Amortization of debt issuance costs |
1,652 |
1,191 |
|
|
239,699 |
- |
|
Loss on extinguishment of debt and write-off of debt issuance costs |
- |
2,699 |
|
Share of net income from joint venture, net of cash dividends received |
271 |
(269) |
|
Compensation expense from issuance of share-based awards |
1,296 |
873 |
|
Deferred income taxes |
(3,923) |
(5,704) |
|
Other |
614 |
182 |
|
Changes in operating assets and liabilities, excluding acquisitions: |
|||
Accounts receivable |
1,760 |
(13,963) |
|
Inventories |
(2,507) |
(5,625) |
|
Accounts payable |
3,584 |
7,236 |
|
Income taxes receivable and payable, net |
(12,676) |
1,579 |
|
Other |
5,461 |
5,182 |
|
Net cash provided by (used in) operating activities |
10,224 |
(2,712) |
|
Cash flows from investing activities |
|||
Acquisition of property, plant and equipment, net of acquisitions |
(11,260) |
(14,073) |
|
Short-term investment |
- |
8,000 |
|
Proceeds from sale of property, plant, and equipment |
82 |
2,395 |
|
Other |
- |
(1) |
|
Net cash provided by (used in) investing activities |
(11,178) |
(3,679) |
|
Cash flows from financing activities |
|||
Cash paid for debt issuance or prepayment costs |
(286) |
(738) |
|
Dividends paid |
- |
(2,947) |
|
Proceeds from long-term debt |
60,012 |
19,025 |
|
Repayment of long-term debt |
(4,527) |
(7,522) |
|
Proceeds from (repayments of) short-term debt, net |
(411) |
1,982 |
|
Other |
(888) |
(924) |
|
Net cash provided by (used in) financing activities |
53,900 |
8,876 |
|
Effect of exchange rate changes on cash flows |
(5,435) |
(204) |
|
Net change in cash and cash equivalents |
47,511 |
2,281 |
|
Cash and cash equivalents at beginning of period |
31,703 |
17,988 |
|
Cash and cash equivalents at end of period |
$ 79,214 |
$ 20,269 |
Reconciliation of GAAP Income from Operations to Non-GAAP Adjusted Income from Operations |
||||||
Three Months Ended |
Three Months Ended |
|||||
$000s |
|
$000s |
|
|||
|
2020 |
2019 |
Power Solutions |
2020 |
2019 |
|
GAAP income from operations |
|
$ (317) |
GAAP income from operations |
$ (90,334) |
$ 3,824 |
|
Restructuring and integration expense |
- |
(12) |
Restructuring and integration expense |
- |
- |
|
Acquisition and transition expense* |
11,418 |
10,069 |
Acquisition and transition expense |
1,621 |
1,832 |
|
Amortization of intangibles |
11,342 |
12,650 |
Amortization of intangibles |
2,748 |
2,748 |
|
Impairments ( |
239,706 |
- |
Impairments ( |
92,948 |
- |
|
Non-GAAP adjusted income from operations (a) |
$ 17,135 |
$ 22,390 |
Non-GAAP adjusted income from operations (a) |
$ 6,983 |
$ 8,404 |
|
Non-GAAP adjusted operating margin (1) |
8.6% |
10.5% |
Non-GAAP adjusted operating margin (1) |
15.0% |
16.9% |
|
GAAP net sales |
$ 199,745 |
$ 213,256 |
GAAP net sales |
$ 46,401 |
$ 49,657 |
|
Three Months Ended |
Three Months Ended |
|||||
$000s |
|
$000s |
|
|||
Mobile Solutions |
2020 |
2019 |
Life Sciences |
2020 |
2019 |
|
GAAP income from operations |
$ 264 |
$ 3,189 |
GAAP income from operations |
|
$ 3,846 |
|
Restructuring and integration expense |
- |
(12) |
Restructuring and integration expense |
- |
- |
|
Acquisition and transition expense |
383 |
1,692 |
Acquisition and transition expense |
2,534 |
4,342 |
|
Amortization of intangibles |
838 |
885 |
Amortization of intangibles |
7,755 |
9,017 |
|
Impairments ( |
- |
- |
Impairments ( |
146,758 |
- |
|
Non-GAAP adjusted income from operations (a) |
$ 1,486 |
$ 5,754 |
Non-GAAP adjusted income from operations (a) |
$ 16,068 |
$ 17,205 |
|
Share of net income from joint venture |
(271) |
269 |
Non-GAAP adjusted operating margin (1) |
19.1% |
20.0% |
|
Non-GAAP adjusted income from operations with JV |
1,215 |
6,023 |
GAAP net sales |
$ 84,048 |
$ 86,008 |
|
Non-GAAP adjusted operating margin (1) |
1.7% |
7.7% |
||||
GAAP net sales |
$ 69,884 |
$ 78,075 |
||||
Three Months Ended |
||||||
$000s |
|
|||||
Elimination |
2020 |
2019 |
||||
GAAP net sales |
$ (588) |
$ (484) |
||||
(1) Non-GAAP adjusted operating margin = Non-GAAP adjusted income from operations/ GAAP net sales |
||||||
* 2020 Includes Capacity & Capabilities Dev - |
||||||
2019 Includes Capacity & Capabilities Dev - |
Reconciliation of Net Income (Loss) to Non-GAAP Adjusted EBITDA |
|||
Three Months Ended |
|||
|
|||
$000s |
2020 |
2019 |
|
GAAP net income (loss) |
|
$ (19,518) |
|
Provision (benefit) for income taxes |
(15,609) |
2,241 |
|
Interest expense |
17,077 |
13,801 |
|
Write-off of unamortized debt issuance cost |
- |
2,699 |
|
Change in fair value of preferred stock tax withholding |
(57) |
- |
|
Depreciation and amortization |
23,184 |
23,425 |
|
Acquisition and transition expense |
11,267 |
9,831 |
|
Non-cash stock compensation |
1,296 |
874 |
|
Non-cash foreign exchange (gain) loss on inter-company loans |
1,686 |
499 |
|
Restructuring and integration expense |
- |
(12) |
|
Impairments ( |
239,706 |
- |
|
Non-GAAP adjusted EBITDA (b) |
$ 30,359 |
$ 33,839 |
|
Non-GAAP adjusted EBITDA margin (2) |
15.2% |
15.9% |
|
GAAP net sales |
$ 199,745 |
$ 213,256 |
|
(2) Non-GAAP adjusted EBITDA margin = Non-GAAP adjusted EBITDA / GAAP net sales |
Reconciliation of Net Income (Loss) to Non-GAAP Adjusted Net Income (Loss) and Net |
|||
Three Months Ended |
|||
|
|||
$000s |
2020 |
2019 |
|
GAAP net income (loss) |
$ (248,191) |
$ (19,518) |
|
Pre-tax acquisition and transition expense |
11,418 |
10,069 |
|
Pre-tax foreign exchange (gain) loss on inter-company loans |
1,686 |
499 |
|
Pre-tax restructuring and integration expense |
- |
(12) |
|
Pre-tax write-off of unamortized debt issuance costs |
- |
2,699 |
|
Pre-tax change in fair value of preferred stock tax withholding |
(57) |
- |
|
Pre-tax amortization of intangibles and deferred financing costs |
12,995 |
13,841 |
|
Pre-tax impairments of fixed asset costs |
7 |
- |
|
Tax effect of adjustments reflected above (c) |
(5,393) |
(5,741) |
|
Non-GAAP discrete tax adjustments |
(11,929) |
6,000 |
|
Impairments ( |
239,699 |
- |
|
Non-GAAP adjusted net income (loss) (d) |
$ 236 |
$ 7,837 |
|
Three Months Ended |
|||
|
|||
Amounts per share, diluted |
2020 |
2019 |
|
GAAP net income (loss) per diluted share |
$ (5.96) |
$ (0.47) |
|
Pre-tax acquisition and transition expense |
0.27 |
0.24 |
|
Pre-tax foreign exchange (gain) loss on inter-company loans |
0.04 |
0.01 |
|
Pre-tax restructuring and integration expense |
- |
(0.00) |
|
Pre-tax write-off of unamortized debt issuance costs |
- |
0.06 |
|
Pre-tax change in fair value of preferred stock tax withholding |
(0.00) |
- |
|
Pre-tax amortization of intangibles and deferred financing costs |
0.31 |
0.33 |
|
Pre-tax impairments of fixed asset costs |
0.00 |
- |
|
Tax effect of adjustments reflected above (c) |
(0.13) |
(0.14) |
|
Non-GAAP discrete tax adjustments |
(0.28) |
0.14 |
|
Impairments ( |
5.69 |
- |
|
Preferred stock cumulative dividends and deemed dividends |
0.07 |
- |
|
Non-GAAP adjusted net income (loss) per diluted share (d) |
$ 0.01 |
$ 0.19 |
|
Weighted average shares outstanding, diluted |
42,111 |
41,972 |
Reconciliation of Operating Cash Flow to Free Cash Flow |
|||
Three Months Ended |
|||
|
|||
$000s |
2020 |
2019 |
|
Net cash provided (used) by operating activities |
$ 10,224 |
$ (2,712) |
|
Acquisition of property, plant and equipment |
(11,260) |
(14,073) |
|
Free Cash Flow |
$ (1,036) |
$ (16,785) |
Reconciliation of Net Debt |
|||
|
|
||
$000s |
2020 |
2019 |
|
Short term debt & finance lease liability |
$ 23,207 |
$ 35,845 |
|
Long term debt and finance lease liability (ex- issuance costs) |
824,897 |
832,424 |
|
Funded debt |
848,104 |
868,269 |
|
Cash and cash equivalents |
79,214 |
20,268 |
|
Net debt |
$ 768,890 |
$ 848,001 |
The Company discloses in this presentation the non-GAAP financial measures of adjusted income from operations, adjusted EBITDA, adjusted net income (loss), adjusted net income per diluted share, free cash flow and net debt. Each of these non-GAAP financial measures provides supplementary information about the impacts of acquisition, divestiture and integration related expenses, foreign-exchange impacts on inter-company loans, reorganizational and impairment charges. Over the past five years, we have completed seven acquisitions, two of which were transformative for the Company, and sold two of our businesses. The costs we incurred in completing such acquisitions, including the amortization of intangibles and deferred financing costs, and these divestitures have been excluded from these measures because their size and inconsistent frequency are unrelated to our commercial performance during the period, and which we believe are not indicative of our ongoing operating costs. We exclude the impact of currency translation from these measures because foreign exchange rates are not under management's control and are subject to volatility. Other non-operating charges are excluded as the charges are not indicative of our ongoing operating cost. We believe the presentation of adjusted income from operations, adjusted EBITDA, adjusted net income (loss), adjusted net income per diluted share, free cash flow and net debt provides useful information in assessing our underlying business trends and facilitates comparison of our long-term performance over given periods.
The non-GAAP financial measures provided herein may not provide information that is directly comparable to that provided by other companies in the Company's industry, as other companies may calculate such financial results differently. The Company's non-GAAP financial measures are not measurements of financial performance under GAAP and should not be considered as alternatives to actual income growth derived from income amounts presented in accordance with GAAP. The Company does not consider these non-GAAP financial measures to be a substitute for, or superior to, the information provided by GAAP financial results.
(a) Non-GAAP adjusted income from operations represents GAAP income from operations, adjusted to exclude the effects of restructuring and integration expense; non-operational charges related to acquisition and transition expense, intangible amortization costs for fair value step-up in values related to acquisitions, non-cash impairment charges, and when applicable, our share of income from joint venture operations. We believe this presentation is commonly used by investors and professional research analysts in the valuation, comparison, rating and investment recommendations of companies in the industrial industry. We use this information for comparative purposes within the industry. Non-GAAP adjusted income from operations is not a measure of financial performance under GAAP and should not be considered as a measure of liquidity or as an alternative to GAAP income from operations.
(b) Non-GAAP adjusted EBITDA represents GAAP net income (loss), adjusted to include income taxes, interest expense, Interest rate swaps and write-offs, depreciation and amortization, charges related to acquisition and transition costs, non-cash stock compensation expense, foreign exchange gain (loss) on inter-company loans, restructuring and integration expense, income from discontinued operations, and non-cash impairment charges, to the extent applicable. We believe this presentation is commonly used by investors and professional research analysts in the valuation, comparison, rating and investment recommendations of companies in the industrial industry. We use this information for comparative purposes within the industry. Non-GAAP adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as a measure of liquidity or as an alternative to GAAP income (loss) from continuing operations.
(c) This line item reflects the aggregate tax effect of all nontax adjustments reflected in the respective table.
(d) Non-GAAP adjusted net income (loss) represents GAAP net income (loss) adjusted to exclude the tax-affected effects of restructuring and integration charges (related to plant closures and other charges incurred to implement our strategic goals that do not necessarily represent a major strategic shift in operations), charges related to acquisition and transition costs, amortization of intangibles costs for fair value step-up in values related to acquisitions and amortization of deferred financing costs, foreign exchange gain (loss) on inter-company loans, estimated interest expense on cash held from divestiture, non-cash impairment charges, the impact of enactment of the Tax Cut and Jobs Act and income from discontinued operations. We believe this presentation is commonly used by investors and professional research analysts in the valuation, comparison, rating and investment recommendations of companies in the industrial industry. We use this information for comparative purposes within the industry. Non-GAAP adjusted income (loss) from segment operations is not a measure of financial performance under GAAP and should not be considered as a measure of liquidity or as an alternative to GAAP income (loss) from continuing operations.
View original content:http://www.prnewswire.com/news-releases/nn-inc-reports-first-quarter-2020-results-301055443.html
SOURCE
Claire Walsh, Abernathy Macgregor, (212) 371-5999